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Passive smoking
Study was flawed from outset
Editor—The study by Enstrom and Kabat
has a major flaw,1 and I urge the editors of
the BMJ to consider a retraction. The study
assumes a considerable difference in the
exposure to environmental tobacco smoke
of never smokers’ spouses compared to ever
smokers’ spouses. This is obviously wrong.
Most never smokers’ spouses would
have been exposed to considerable environ-
mental tobacco smoke before the late 1990s
when Californian public places became
smoke-free. Thus for most of the study
period, assuming the spouses are together
for two to four waking hours a day, the com-
parison is eight to10 hours’ exposure to
tobacco smoke among spouses of never
smokers and 12 hours’ exposure to tobacco
smoke among spouses of ever smokers.
Assuming passive smoking increases mor-
tality by 30%, the demonstrable difference
between the groups would be about 5%
((12 − 10)/12)×30). This would be further
reduced because of quitters among ever
smokers and occasional smokers among
never smokers. A 5% difference is extremely
difficult to show in an epidemiological study,
and inability to find a difference cannot be
taken as absence of a difference.
However flawed this study, unless it is
retracted by the BMJ the tobacco industry will
use it to promote their vigorous opposition to
antismoking legislation in general, and
anti-environmental tobacco smoke laws in
particular, creating controversy where there
isn’t any. Of course they have an urgent and
ongoing need to replace loss of their
customer base—10 000-20 000 lives per day—
with new recruits of young smokers.
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Wider evidence needs to be interpreted
Editor—Enstrom and Kabat’s analysis has
several omissions.1 First they accept that
most epidemiological studies have found
positive but not statistically significant
relationships between environmental
tobacco smoke, coronary heart disease, and
lung cancer, but then argue against meta-
analysis to establish a causal relation. This is
precisely where systematic reviews, and
sometimes meta-analysis, show considerable
benefit by increasing power. Enstrom and
Kabat say that publication bias may explain
positive results in reviews; however, larger
cohort studies, unlike small trials and
reports, are more likely to be published,
regardless of results.2 They do not explain
heterogeneity between their findings and
others, simply arguing that their cohort is
large, and has more strengths. In fact, large
prospective cohort studies like this may have
greater losses to follow up, or more misclas-
sification, over time.3
Misclassification, mentioned by the
authors, may explain the apparent lack of
association. Furthermore, the relative risks
reported for active smoking and coronary
heart disease (relative risk 1.5, table 10 in the
paper) are lower than other cohort studies,
which may be sufficient to obscure a modest
but important increase in risk.4 5 They
further assume an (unlikely) linear relation
between cigarette smoking and mortality to
validate their main results (extrapolating a
very low estimate of a relative risk of 1.03 for
coronary heart disease, by implying that
environmental tobacco smoke is equivalent
to smoking one cigarette per day). This
analysis is unclear and unconvincing.
One study is insufficient to overturn
established relations between environmen-
tal tobacco smoke and mortality, and I think
that the authors overemphasise their
negative findings.
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Paper does not diminish conclusion of
previous reports
Editor—I am writing on behalf of members
of the 2002 working group on involuntary
smoking and cancer for the International
Agency for Research on Cancer (IARC).1 We
concluded that environmental tobacco
smoke causes lung cancer among never
smokers. The paper by Enstrom and Kabat2
does not diminish this conclusion or those
of previous reports.3–5
Enstrom and Kabat’s paper was based
on one of the 25 US states (California) in the
American Cancer Society’s prevention study.
The relative risk of lung cancer in never
smoking women married to ever smokers
was reported as 0.99 (95% confidence inter-
val 0.72 to 1.37), based on only 177 cases,
whereas the IARC meta-analysis, based on
46 studies and 6257 cases, yielded an
estimate of 1.24 (95% confidence interval
1.14 to 1.34).1 The estimate of Enstrom and
Kabat is consistent with both an increased
risk of lung cancer (the confidence interval
includes the IARC estimate of 1.24) and no
effect. Adding the result from Enstrom and
Kabat to the IARC analysis reduces the
pooled estimate to 1.23.
The observed relative risk of 0.99 is
based on the smoking status of husbands in
1959, but many would have quit by 1998,
particularly in California. Table 8 in the
paper confirms this; in 1959 63% of ever
smoking husbands were current smokers
compared with 26% in 1998. This exposure
misclassification would mask the association
between exposure to environmental tobacco
smoke and lung cancer.
IARC’s classification of environmental
tobacco smoke as a human carcinogen was
based on the full scope of evidence; observa-
tional studies, carcinogenic components of
environmental tobacco smoke, experimen-
tal models, and biomarker studies. Addition-
ally, active smoking is an established cause of
lung cancer, and knowledge of mechanisms
of carcinogenesis implies no risk free level of
exposure to tobacco smoke. Enstrom and
Kabat’s conclusions are not supported by
the weak evidence they offer, and, although
the accompanying editorial alluded to
“debate” and “controversy,” we judge the
issue to be resolved scientifically, even
though the “debate” is cynically continued
by the tobacco industry.
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Inverse correlation of smoking and
education should have raised suspicion
Editor—It is well known that smoking is
inversely correlated with education level; the
highest percentage of smokers is found
among those people who have not com-
pleted high school. This inverse correlation
of smoking and education has been true for
many years. It is referred to in the 15th edi-
tion (1977-9) of the Encyclopedia Britannica.
Clearly, this casts suspicion on the data entry
and the programming used by Enstrom and
Kabat to perform their analysis,1 because
they find that the highest frequency of
smoking is associated with the highest level
of education.
From their table 2 (male never smokers)
and table 3 (female never smokers) sorted by
smoking status of spouse, they show that the
heaviest smokers ( ≥ 40 cigarettes/day) are
more likely to have completed high school
than are non-smokers. Further, among smok-
ers, they show that for those smoking a higher
number of cigarettes the likelihood of
completing high school is greater.
Because the “never smoked/formerly
smoked” group does not show the expected
higher proportion of high school graduates,
this implies that there were a sizeable
number of smokers included among the
non-smokers; that would account for the
spouses of “non-smokers” not exhibiting a
lower rate of heart disease.
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Secondhand smoke does cause
respiratory disease
Editor—The report by Enstrom and Kabat
confirms that exposure to secondhand
smoke causes injury to the respiratory
system with the finding of a combined
increased mortality risk for men and women
for chronic obstructive pulmonary disease
(relative risk 1.65, 95% confidence interval
1.0 to 2.73).1 This is consistent with other
investigations that show the sensitivity of the
respiratory system to secondhand smoke at
all ages and in different settings. In Hong
Kong several studies have shown that the
exposure of infants to secondhand smoke in
utero or postnatally in the home was linked
to higher consultation rates and hospitalisa-
tion for respiratory and other illnesses.2
Smoking in the home was clearly associated
with bronchitic symptoms in a cohort of pri-
mary school children, independently of
ambient air pollution.3 In an adult work-
force, workplace exposures to passive smok-
ing were associated with significant excess
risks (66% to 212%) for all respiratory symp-
toms and increased healthcare costs.4 In a
population survey the prevalence of second-
hand smoke exposures at work was 47.5%
among non-smoking full time workers com-
pared with only 26% at home. People
exposed at work were 37% more likely to
consult a doctor for respiratory illness. The
increased healthcare costs for primary care
alone among three million workers was esti-
mated at US$29m (£18m; €26m) annually.5
Four independent case control studies on
lung cancer and passive smoking in Hong
Kong, reviewed by the United States
Environmental Protection Agency, gave an
overall relative risk of 1.48 (1.21 to 1.81).
In other words, we have epidemics of
respiratory disease in Hong Kong caused by
secondhand smoke.However, because of the
way in which the Enstrom and Kabat paper
was presented little or no attention will be
paid in media reports to the findings on
mortality risks from respiratory disease.
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Doubts about effectiveness of age
adjustment
Editor—According to Enstrom and Kabat’s
figures the greater had been a man’s
cigarette consumption in 1959 the less
likely, it seems, was the death of his wife from
coronary heart disease.1 However, an age
bias existed in those women at the outset. In
1959 their mean age decreased with spousal
smoking, such that the wives of men
smoking 40 a day were a mean four years
younger than wives of men smoking one to
19 a day, probably as a consequence of early
death of smoking husbands of similarly aged
wives (table 3 on bmj.com).
During the study period mortality from
coronary heart disease fell by about 15%
every four years.2 The “passive” smokers
were therefore predominantly from later
cohorts for whom, age for age, mortality
from coronary heart disease had fallen
significantly in comparison to controls. The
same argument applies to never smoking
husbands of smoking women who had an
average age four to five years lower than
controls (table 2 on bmj.com). Adjusting for
age alone will not remove this interaction of
age and time of observation.
Moreover, the Cox proportional hazard
model is critically dependent on assumed
proportionality between two survival curves
at all points following entry to the study.3
Mortality from coronary heart disease
increases almost exponentially for most of
adult life and the mortality curves of risk
groups for coronary heart disease differ not
only in scale but also in doubling time. As
such their survival curves cannot be propor-
tional, yet this was not tested.
The effectiveness of age adjustment in
this study is questionable, the year of obser-
vation should have been taken into account,
and the statistical method is potentially
unsound. The biological implausibility of
the trend in relative risk may well be an
expression of systematic bias in the method.
Eugene Milne deputy medical director
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Tobacco industry publishes
disinformation
Editor—The American Cancer Society
does not agree with the conclusions of
Enstrom and Kabat in their analysis of envi-
ronmental tobacco smoke in the cancer pre-
vention study I (CPS-I).1 Their study is fatally
flawed because of misclassification of expo-
sure. The cancer prevention study was
started by the society in 1959 to measure the
effects of active smoking, not to collect valid
estimates of exposure to environmental
tobacco smoke.2 No information was
obtained on sources of exposure to environ-
mental tobacco smoke other than the smok-
ing status of the spouse. Tobacco smoke was
so pervasive in the United States in the
1950s and 1960s that virtually everyone was
exposed, at home, at work, or in other
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settings. Enstrom and Kabat essentially
compare non-smokers, married to a smok-
ing spouse, with non-smokers with other
sources of exposure to environmental
tobacco smoke. Misclassification of expo-
sure is compounded because no infor-
mation was collected on the smoking status
of the spouse between 1972 and 1999. Non-
smokers whose spouses reported smoking
at the start of the study are classified as
“exposed” even if the spouse quit, died, or
the marriage ended during this interval.
This problem is not solved by the 1999
resurvey of survivors, since these represent
only 2% of the original analytic cohort and
5% of those followed after 1972. Other seri-
ous flaws of the Enstrom and Kabat paper
are discussed elsewhere.3
This is the second attempt by tobacco
industry consultants to publish flawed
analyses of environmental tobacco smoke
using cohort studies from the American
Cancer Society.4 Sadly, the forum in which
such studies are influential is not the
scientific world—scientists recognise these
studies for what they are—but in communi-
ties that are considering clean air laws.
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Peer review and press release
Editor—The questions raised about the
validity of the data reported by Enstrom and
Kabat call into question the adequacy of the
peer and editorial review of the paper at the
BMJ.1 Apparently no one with special exper-
tise in research on the health effects of pas-
sive smoking was involved in the review of
this paper. In an area as complex as this—to
which massive reports have been
devoted2 3—one or more persons with epide-
miological expertise and an extensive
knowledge of the literature on this subject
should have been involved in the review of
this paper. The obligation to find such a
reviewer is heightened when one considers
the authors’ conflicts of interest and the fact
that the paper challenges a huge body of
evidence in an area of enormous public
health importance.
The BMJ ’s press release for this paper
looks as if it was written by the tobacco
industry. It refers to the “already controver-
sial debate on the health impact of passive
smoking” and mostly parrots the views of
Enstrom and Kabat. In its eight paragraphs,
the release allocates three words to the
study’s limitations. The coup de grâce is that
the release does not mention the authors’
conflicts of interest. This problem is not
unique to the BMJ. An analysis of press
releases issued by seven medical journals
(including the BMJ ) included 23 studies that
were industry funded; only 22% of the
corresponding press releases revealed the
source of funding.4
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Agreeing the limits of conflicts of interest
Editor—The paper by Enstrom and Kabat1
raises the issue of how much conflict of
interest can editors reasonably allow before
the findings and interpretation of a particu-
lar study are rendered unsafe or, at the very
least, too uncertain to be a substantive scien-
tific contribution?
If we think that there really is a limit to
the degree of conflict that we judge reason-
able, as some responses to the Enstrom and
Kabat paper seem to imply, then criticism
should be directed to the medical commu-
nity for having such imprecise thinking over
conflicts of interest. In pharma sponsored
studies, we mostly allow conflicts provided
they are reported accurately. We deplore
them in tobacco sponsored research. But
there are many examples of how both
industries have tried to undermine the inde-
pendence and rigour of research, bias policy
makers, and gouge huge profit from disease.
In papers from the pharma industry we
publish a statement about the role of the
funding source in the design, conduct,
analysis, and reporting of the data for all pri-
mary research, irrespective of who the spon-
sor might be (for-profit, not-for-profit etc).
No such statement appears in the Enstrom
and Kabat paper—would this have helped
readers judge the safety and reliability of
their research?
Could this paper therefore provide a
useful opportunity for us all to clarify what is
an acceptable conflict, for readers, research-
ers, and editors alike, and how that conflict
should be reported? Could we agree also
about how to handle these matters during
prepublication peer review (should the
extent of the conflict be a factor, in addition
to the science, in deciding acceptance or
rejection?)—well before they might confuse
an already difficult scientific issue of great
public concern?
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Background must be examined
Editor—The reviews of the paper by
Enstrom and Kabat and the responses to
them raise serious concerns about this
paper,1 strengthened by what has since
emerged about one of the author’s links to
the tobacco industry. As an editor who has
been misled by an ostensibly independent
scientist later found to be a consultant for the
tobacco industry, I am hesitant to criticise
others who may find themselves in a
potentially similar position as discovering
the full story can be lengthy and painful.2
One must consider not just the scientific
merits of what was published but also the
many analyses that could be but were not.
One must also scrutinise carefully statements
that could be genuine differences of
interpretation but may reflect other motives.
Especially where passive smoking is con-
cerned, it is essential to examine the
background to the study, given the un-
precedented resources used by the
tobacco industry in their attempts to create
uncertainty.3
What should happen now? The BMJ
often responds to controversial papers by
simply counting responses for and against.
This is insufficient, given the many unan-
swered questions raised by industry docu-
ments about the part played by senior
tobacco industry executives and their con-
sultants in this paper.4 When faced with
similar questions about a paper we pub-
lished on passive smoking we undertook a
full investigation, producing evidence that
was subsequently used successfully in a legal
action in Switzerland.5 Without prejudging
the outcome, such a review would, prima
facie, also seem to be justified in this case.
Competing interests: See reference 4.
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Authors’ reply
Editor—Owing to the charged atmosphere
surrounding the issue of passive smoking,
our paper provoked strong reactions on
bmj.com. The most disturbing reactions
have come from the enforcers of political
correctness who pose as disinterested scien-
tists but are willing to use base means to
trash a study whose results they dislike. They
have no qualms about engaging in personal
attacks and unfounded insinuations of
dishonesty rather than judging research on
its merits.1 The resulting confusion has mis-
led many readers and diverted attention
from the facts of the study.
Since 15 May Michael Thun of the
American Cancer Society has led a cam-
paign to discredit our study, including his
letter above. However, almost every sentence
in his letter is misleading, and he disregards
key information in the full version of our
paper. Contrary to the title of his letter, we
have presented an accurate analysis of the
California cohort of the cancer prevention
study I (CPS I), not disinformation, and it
comes from the University of California, Los
Angeles, and the State University of New
York, Stony Brook, not the tobacco industry.
Anyone who reads the full version of the
paper and our response to the reviewers of 9
January2 will see that in fact we provided
detailed evidence that refutes the claim that
our study is “fatally flawed because of
misclassification of exposure.” Contrary to
Thun’s unsubstantiated assertion that
“tobacco smoke was so pervasive in the
United States in the 1950s and 1960s that
virtually everyone was exposed, at home,
work, or in other settings,” the table shows
that most female never smokers married to
never smokers were not exposed. It also
shows that 1959 spousal smoking was
strongly related to self reported total
exposure to environmental tobacco smoke
as of 1999, in spite of the misclassification of
exposure that occurred over 40 years.
Thun also attempts to minimise our
recontact of survivors in 1999. Instead of the
2% and 5% he cites, we obtained 1999
responses from 8.7% (3094/35561) of the
subjects alive on 1 January 1960, from 35.6%
(3094/8693) of the subjects known to be
alive as of 31 December 1998, and from
about 45% of the subjects who actually
received the questionnaire (see table 1 and
text of full paper). In addition, we have
shown in tables 2 and 3 that the 1999
respondents were reasonably representative
of the 1959 subjects. Thun claims that “mis-
classification of exposure is compounded
because no information was collected on the
smoking status of the spouse between 1972
and 1999,” but he completely ignores table
9. This table clearly shows that results for
coronary heart disease for follow up periods
of 6, 7, and 13 years, when exposure misclas-
sification would be minimised, were the
same as the results in tables 7 and 8 for
follow-up periods of 26 and 39 years.
Furthermore, although Thun is in a
position to check our results by analysing
the data from CPS I, he has yet to identify a
single error. His attack should be seen for
what it is—an attempt to discredit work that
is at variance with the position he is commit-
ted to. However, the evidence for the health
effects of passive smoking is neither as con-
sistent nor as iron clad as Thun wants to
portray it. Rather, the widely accepted
evidence is the result of selective reporting
of data and, when necessary, attempts to
suppress divergent data. Our paper provides
a prime example of these tactics.
Horton has posed serious questions
regarding the issues of conflict of interest and
the difficulty of determining the credibility of
research findings, particularly those that
involve tobacco industry funding. We suggest
four things be done for controversial papers
such as ours. Firstly, the integrity of the
authors should be thoroughly and fairly
investigated. In our case, we both have a sub-
stantial record of accomplishment in con-
ducting relevant epidemiologic studies and,
until now, we have never had our professional
integrity challenged. Secondly, full disclosure
should be made regarding conflicts of
interest, as has been done with our paper. We
want to make clear that the tobacco industry
played no part in our paper other than
providing the final portion of the funding.
The tobacco industry never saw any version
of our paper before it was published, never
attempted to influence the writing of the
paper in any way, and did not even know the
paper was being published until it became
public. In addition, we have never testified on
behalf of the tobacco industry, never owned
any stock in the tobacco industry, never been
employees of the tobacco industry, and would
never have accepted tobacco industry funds if
there had been any other way to conduct this
study. However, full disclosure must be
required of all authors and organisations. In
particular, what are the competing interests
of Thun, and where does the American Can-
cer Society get its funds? Thirdly, and most
importantly, the integrity of the underlying
data must be thoroughly and fairly investi-
gated. The best way to resolve questions
about the validity of research findings is
through independent examination of the
underlying data, something that is now
required in principle by the Data Quality Act
for US studies with public policy implica-
tions.3 Fourthly, journals must be willing to
publish and discuss controversial findings, as
long as they meet the criteria of good science.
Regarding the comments of the working
group of the International Agency for
Research on Cancer (IARC), we have not
claimed that our study changes the weight of
the worldwide evidence on environmental
tobacco smoke and lung cancer, but it does
change the US evidence. When our results
are included, meta-analysis of US results on
environmental tobacco smoke and lung
cancer among both men and women yields
a summary relative risk of about 1.10 for
ever/never exposure, which is just on the
border of statistical significance. Our results
have an even greater impact with regard to
environmental tobacco smoke and coronary
heart disease, where meta-analysis of US
results, which constititute most of the
evidence, yields summary relative risks of
about 1.05 for current/never and ever/
never exposure. The end of our response to
the reviewers summarises the relative risks
for environmental tobacco smoke and
coronary heart disease by exposure status
for all US cohort studies.2 Because of our
findings, we conclude that “the association
between exposure to environmental tobacco
smoke and coronary heart disease and lung
cancer may be considerably weaker than
generally believed.” Finally, we do not think
the weak association with lung cancer means
that environmental tobacco smoke “causes”
lung cancer, and we certainly do not think
that this issue is “resolved scientifically.”
In response to Glaser and Milne, we
have used a standard method of analysis for
prospective cohort data: Cox proportional
hazards regression based on the SAS
PHREG program.4 All results have been
properly adjusted for age at entry, which is
by far the strongest risk factor for death.
Tables 7 and 8 show that confounding vari-
ables such as education have virtually no
effect on the relative risks. Too much is
being made of statistical fluctuations in
tables 2 and 3. For a fair evaluation of our
study, it must be put in perspective with
all other similar studies, which has not yet
been done.
Finally, we too are in favour of the
strongest possible protections for non-
smokers. However, the attempt to suppress
any divergent results because of their possi-
ble effect on public policy can only harm
science in the long run. In a rational society,
there are ample grounds for regulating
involuntary exposure to tobacco smoke
without manipulating scientific results.What
is most dangerous is the willingness to
Self reported total exposure to environmental tobacco smoke among female never smokers in the
California cohort of the cancer prevention study I by smoking status of spouse (taken mainly from
tables 4 and 5 of full paper)
History of regular exposure to cigarette smoke from others in
work or daily life as of 1999 (%)
Smoking status of spouse None Light Moderate Heavy
Low exposure:
Married to a never smoker as of 1959 61.7 24.3 10.9 3.1
Married to a never smoker as of 1972 63.6 23.9 9.7 2.8
Never married to a smoker as of 1999 76.7 16.1 5.3 1.9
High exposure:
Married to a smoker of 40+ cigarettes per day as of 1959 16.2 12.5 47.5 23.8
Exposed 40+ years to a smoking spouse as of 1999 14.1 20.5 44.3 21.1
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distort the truth to defend one’s position,
claiming all along that science and right-
eousness are on one’s side.
James E Enstrom researcher
School of Public Health, University of California,
Los Angeles, CA 90095-1772, USA
jenstrom@ucla.edu
Geoffrey C Kabat associate professor
Department of Preventive Medicine, State
University of New York, Stony Brook, NY
11794-8036, USA
1 Rothman KJ. Conflict of interest: the new McCarthyism in
science. JAMA 1993;269:2782-4.
2 Enstrom JE, Kabat GC. Response to BMJ/2002/011163
Manuscript Decision. BMJ 2003. bmj.com/cgi/content/
full/326/7398/1057/DC1/7 (accessed 16 Aug 2003).
3 Data Quality Act and OMB Guidelines. Guidelines for
ensuring and maximizing the quality, objectivity, utility,
and integrity of information disseminated by federal agen-
cies; notice; republication. Federal Register
2002;67(36):8451-60. (Friday, 22 February.)
www.isrl.uiuc.edu/qrd/iq/public/data-quality-
guidelines.html (accessed 16 Aug 2003).
4 So Y. The PHREG procedure. In: SAS/STAT software. SAS
technical report P-229. Cary, NC: SAS Institute, 1992.
support.sas.com/documentation/onlinedoc/index.html
(accessed 19 Aug 2003).
Summary of rapid responses
Editor—More than 140 readers responded
to Enstrom and Kabat’s paper and Davey
Smith’s editorial.1 2 Some of the passion and
most of the science is captured in the letters
above. What follows is a necessarily brief
overview of the remaining ones. The debate
started with some orthodox critical com-
ment on the paper: the analysis underesti-
mated the risk to passive smokers, was
underpowered, distorted, poorly reported,
placed out of context, or just plain wrong.
The two main contentions were that a smok-
ing spouse is a poor proxy for passive smok-
ing (because everyone smoked in the 1950s,
so people with non-smoking spouses were
still exposed at work), and that many quitters
are misclassified as smokers. Both would
reduce the difference in mortality between
exposed and non-exposed groups. In gen-
eral, the criticisms were poorly substanti-
ated; only four letters (3%) referred to actual
data in the paper.
The discussions then widened to a
number of more or less polite exchanges
starting with the evils of the tobacco
industry (too numerous to be repeated
here), and the competing evils of drug com-
panies that make nicotine replacement
therapy. Neither side expressed their own
view. Many readers were angry with the BMJ
for publishing this study. More were angry
about the “tabloid” cover on the journal, and
the press release, which they said was sensa-
tional and misleading. Some thought the
BMJ ’s editors were naive, others thought we
were stupid, mad, or irresponsible, and a few
suggested darker motives including raising
our impact factor by publishing a citable
paper. There were calls for a retraction, and
one for an internal inquiry. Here are a few
typical comments. “It is saddening that a
prestigious publication such as BMJ has low-
ered its publication standards to the point of
letting a piece of rubbish occupy its columns
and amplifying it with a complaisant
editorial.” “I cannot believe that a reputable
journal such as the British Medical Journal
can seriously print such a flawed study
except to increase readership and create
controversy” and “BMJ, what have you
done?” The outrage had three themes: the
study was bad for public health and should
not have been published. Its conclusions
were unreliable because the tobacco indus-
try paid for them. And the methods and
analysis were scientifically flawed. How
could the paper have got through peer
review? You can read our reviewers’ com-
ments, and an original, unedited draft of
Davey Smith’s editorial on bmj.com.
A dozen or so readers defended us. “You
are to be congratulated for having the cour-
age to publish research that, while politically
incorrect and therefore destined to be exco-
riated by the anti-smoker lobbyists (many of
whom work for anti-smoking organizations
and therefore have obvious conflicts of
interest even if they refuse to cite them)
meets these criteria. Take solace that you are
only being bashed verbally—Galileo paid a
greater price for promulgation of his
research that challenged the worldview of
the catholic majority,” wrote the director of
facilities at an American university. She had
no competing interests to declare.
Neither did most other respondents,
despite some giving tell tale addresses such
as Smoke Free Educational Services Inc,
Smoke Free Pennsylvania, Adults Saving
Kids, and Forces International (an advocacy
group for smokers). One reader thought the
BMJ was being ironic, asking them for a
competing interest statement, and a few oth-
ers simply wrote “I enjoy smoking” or “I quit
smoking.” Enstrom and Kabat wrote over
200 words explaining their funding and
competing interests, but it wasn’t enough.
Both were accused of “swimming with
sharks” and asked to clarify their dealings
with the tobacco industry. One of them,
Geoffrey Kabat, did so, adding, “To imply
that skepticism about the ‘weak association’
of passive smoking with heart disease and
lung cancer is due to influence from the
tobacco industry is simply wrong-headed.
There is legitimate debate about the effects
of passive smoking on heart disease and
lung cancer. The evidence is not as uniform
or as strong as the activists and scientists
with extra-scientific agendas make out.”
James Enstrom has clarified his dealings
with the tobacco industry in BMJ/2003/
084269. Richard Horton, the editor of the
Lancet, concluded that the entire medical
community is guilty of muddled thinking on
conflicting interests.
Many letters were highly charged and
hostile. “It is astounding how much of the
criticism springs from Ad Hominem argu-
ment rather than from scientific criticism of
the study itself,” wrote a “private citizen”
from Philadelphia PA. “As a publisher of the
leading Austrian medical online news serv-
ice I feel quite embarrassed following the
debate on this article. Many postings look
more like a witch hunt than a scientific
debate,” wrote another. It got bitter, and at
times personal. A great read for anyone
who enjoys a scrap. Disappointing for
readers looking for a dispassionate
appraisal of Enstrom and Kabat’s study and
its implications.
Alison Tonks associate editor
BMJ
1 Enstrom J, Kabat G. Environmental tobacco smoke and
tobacco related mortality in a prospective study of Califor-
nians, 1960-98. BMJ 2003;326:1057-61. (17 May.)
2 Davey Smith G. Effect of passive smoking on health. BMJ
2003;326:1048-9. (17 May.)
Comment from the editor
Editor—I can’t respond to all the points
raised in this debate, and I thought I would
simply share some reflections.
Firstly, we’ve considered again whether
we should we have a blanket policy of refus-
ing to publish research funded by the
tobacco industry. We’ve twice considered
this question in the BMJ and twice decided
against. The BMJ is passionately antitobacco,
but we are also passionately prodebate and
proscience. A ban would be antiscience.
Secondly, we are not in the “truth” busi-
ness. Scientific truths are all provisional.
Most of science falls away as new paradigms
emerge. This doesn’t mean that we are in the
“lies” business, but we are in the “debate”
business. We judged this paper1 to be a use-
ful contribution to an important debate. We
may be wrong, as we are with many papers.
That’s science.
Thirdly, with research papers we first ask
if we are interested in the question. We must
be interested in whether passive smoking
kills, and the question has not been
definitively answered. It’s a hard question,
and our methods are inadequate.
We then peer review the study, but we
are well aware of the extreme deficiencies of
peer review. Of course the study we
published has flaws—all papers do—but it
also has considerable strengths: long follow
up, large sample size, and more complete
follow up than many such studies. It’s too
easy to dismiss studies like this as “fatally
flawed,” with the implication that the study
means nothing.
Fourthly, I found it disturbing that so
many people and organisations referred to
the flaws in the study without specifying
what they were. Indeed, this debate was
much more remarkable for its passion than
its precision.
Richard Smith editor
BMJ
Competing interests: RS is the editor of the BMJ
and accountable for all that it publishes.
1 Enstrom JE, Kabat, GC. Environmental tobacco smoke and
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